Completed PHASE2 INTERVENTIONAL 2-arm NCT06419608

Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

A Phase 2 Multicenter, Randomized, Double-blind, Placebo-controlled, Study to Evaluate the Efficacy and Safety of BHV-7000 Monotherapy in Major Depressive Disorder

Sponsor: Biohaven Therapeutics Ltd.

Conditions Major Depressive Disorder

Interventions BHV-7000 Placebo

Updated 15 times since 2024 Last updated: Jan 5, 2026 Started: May 28, 2024 Primary completion: Nov 7, 2025 Completion: Nov 7, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Major Depressive Disorder, this trial is completed. The trial is conducted by Biohaven Therapeutics Ltd. and has accumulated 15 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

15 versions recorded

Feb 2026 — Present [monthly]

Completed PHASE2

Status: Active Not Recruiting → Completed
Sep 2025 — Feb 2026 [monthly]

Active Not Recruiting PHASE2

Status: Recruiting → Active Not Recruiting
Aug 2025 — Sep 2025 [monthly]

Recruiting PHASE2
Jul 2025 — Aug 2025 [monthly]

Recruiting PHASE2
Jun 2025 — Jul 2025 [monthly]

Recruiting PHASE2

▶ Show 10 earlier versions

Apr 2025 — Jun 2025 [monthly]

Recruiting PHASE2
Mar 2025 — Apr 2025 [monthly]

Recruiting PHASE2
Feb 2025 — Mar 2025 [monthly]

Recruiting PHASE2
Dec 2024 — Feb 2025 [monthly]

Recruiting PHASE2
Nov 2024 — Dec 2024 [monthly]

Recruiting PHASE2
Oct 2024 — Nov 2024 [monthly]

Recruiting PHASE2
Sep 2024 — Oct 2024 [monthly]

Recruiting PHASE2
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Jul 2024 — Aug 2024 [monthly]

Recruiting PHASE2
Jun 2024 — Jul 2024 [monthly]

Recruiting PHASE2

First recorded

May 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biohaven Therapeutics Ltd.

Data source: Biohaven Pharmaceuticals, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Allentown, United States , Anaheim, United States , Austin, United States , Baltimore, United States , Bellevue, United States , Bellflower, United States , Boston, United States , Brooklyn, United States , Cedarhurst, United States , Chicago, United States and 47 more locations